• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Header Right

Search

  • Home
  • Expertise
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Executive Team
      • Study Management
    • History
    • Careers
    • Privacy policy / GDPR
  • Contact

Clare Barnett

Director, Project Management & Chief Operating Officer

As Director of Project Management and Chief Operating Officer at ZEG Berlin, Clare Barnett is responsible for overseeing the company’s research resources and ensuring that all projects are delivered within their scope with minimal risks. On a day-to-day basis, Clare collaborates closely with internal and external stakeholders to develop pharmacoepidemiology studies that meet the exact needs of ZEG Berlin’s clients.  She is passionate about global post-market safety and efficacy studies and leads several initiatives focused on innovating ZEG Berlin’s work processes and expanding the service offering.

Clare Barnett is a medical doctor (M.B.B.S (Hons)) with a Master degree in Public Health (MPH) from the Harvard T.H. Chan School of Public Health.  In addition, she has obtained post-graduate certification in Pharmacovigilance and Pharmacoepidemiology. She has previously worked as a General Practitioner and Medical Officer for the Australian competent authority (Therapeutic Goods Administration) gaining experience in both medical device applications and prescription medications. As a clinician and researcher, Clare is interested in women’s health and complex medical diseases and their impact on quality of life, particularly during a woman’s fertile years. She continues to publish and present extensively.

Publications

Barnett Clare, Möhner Sabine, Do Minh Thai, Heinemann Klaas, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5.
Heinemann Klaas, Barnett Clare, Reed Suzanne, Möhner Sabine, Do Minh Thai, IUD use among parous women and risk of uterine perforation: a secondary analysis Contraception. 2017; Volume 95, Issue 6, Pages 605–607.
Barnett Clare, Bauerfeind Anja, Do Minh Thai, Heinemann Klaas, Influence of age and BMI on risk of venous thromboembolism: a meta-analysis of 246,513 women using combined oral contraceptives based on 521,516 women-years. Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Bauerfeind Anja, Barnett Clare, Do Minh Thai, Heinemann Klaas, The effect of BMI on unintended pregnancy rates amongst users of combined oral contraceptives Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Barnett Clare, Hagemann Christine, Dinger Jürgen, Heinemann Klaas, Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study Eur J Contracept Reprod health Care. 2016; Oct 17:1-7. 10.1080/13625187.2016.1241991.
Amir Lisa, Ryan Kath, Barnett Clare, Delphi survey of international pharmacology experts: an attempt to derive international recommendations for medicine use in lactation Breastfeed Med. 2015; 10(3):168-74. 10.1089/bfm.2014.0144.
Barnett Clare, Hort Kris, Approaches to regulating the quality of hospital services in low- and middle-income countries with mixed health systems: a review of their effectiveness, context of operation and feasibility. The Nossal Institute for Global Health, Health Policy and Health Finance Knowledge Hub Working Paper Series. 2013; Jul; No.32.
Barnett Clare, Heinemann Klaas, Dinger Jürgen, Intrauterine devices and the risk of uterine perforation: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 233.
Heinemann Klaas, Barnett Clare, Dinger Jürgen, Risk factors for uterine perforations during IUD insertion: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 138.
Barnett Clare, Heinemann Klaas, Dinger Jürgen, Complications associated with unintended pregnancies under IUD use: results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 125.
Bardenheuer Kristina, Barnett Clare, Dinger Jürgen, Franke Christian, Risk profile and OC utilization patterns of women enrolled in INAS-SCORE. Pharmacoepidemiology and Drug Safety. 2010; 19:S30.
Dinger Jürgen, Barnett Clare, Möhner Sabine, Assmann Anita, Unintended pregnancies in women using intrauterine devices: Results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2010; 19:S242.

sidebar

Executive Team

  • Klaas Heinemann
  • Christine Hagemann
  • Sabine Möhner
  • Clare Barnett
  • Alfred Pauls
  • Jürgen Dinger
  • Johanna Poppe

Study Management

  • Clare Barnett
  • Divine Akumo
  • Pauline De Corte
  • Christine Hagemann
  • Suzanne Reed
  • Janina Bobrich
  • Anja Bauerfeind
  • Do Minh Thai
  • Sabine Möhner
  • Karl Pauls
  • Klaas Heinemann

Who We Are

ZEG Berlin is a private research institute specialized in conducting post-authorization safety / efficacy studies using primary data collection methods. From protocol development to the final publication of study results, we believe in entering into a collaborative partnership with our clients, striving to develop study designs that are best equipped to deliver quality data that accurately answers the question at hand.

Our specialized team of highly-skilled physicians, epidemiologists and statisticians has extensive experience in the design of studies for complex epidemiological questions and is ready to assist you in developing studies that are best suited to your needs. We are a full-service institute, offering all components for post-authorization medical research – from study design to project implementation, study conduct and the publication and presentation of results.

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Latest News

Eight abstracts have been accepted at the FIGO XXII RIO World Congress of Gynecology and Obstretrics

Congratulations to our Project Management team! This October 2018 they will be headed to Rio de Janeiro, Brazil to present at the FIGO XXII RIO World Congress ... Read More

GDPR (General Data Protection Regulation)

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our new updated privacy policy. The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2019 ZEG Berlin

Impressum

Website by Laura Yeffeth

This site uses cookies: Find out more.